SynthesisEuropean journal of clinical pharmacology2025

A meta-analysis and systematic review of the first Trop-2-targeting antibody-drug conjugate (sacituzumab govitecan) in treating metastatic breast cancer.

Jue Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.